Oxytocin — Veterinary Vademecum Drug Reference

Dosage & Administration Guidelines

Species	Route	Dose	Frequency	Duration & Clinical Notes
Dog	IM, IV, SC	0.5-5 IU per dog (or 0.5-1 IU/kg)	Every 30-60 minutes as needed; maximum 3 doses	Duration: Short-term; discontinue if no response after 2-3 doses Notes: Use low doses initially; monitor uterine contractions and fetal heart rate. IV administration should be slow (diluted in saline).
Cat	IM, IV, SC	0.5-3 IU per cat (or 0.5-1 IU/kg)	Every 30-60 minutes as needed; maximum 3 doses	Duration: Short-term; discontinue if no response after 2-3 doses Notes: Use low doses; monitor for uterine rupture. IV administration should be slow.
Horse	IV, IM	10-20 IU per horse (or 0.02-0.04 IU/kg)	Every 30-60 minutes as needed; maximum 3 doses	Duration: Short-term; discontinue if no response Notes: For induction of labor, use low doses and monitor closely. For retained placenta, may be given as a slow IV drip.
Cattle	IV, IM, SC	20-100 IU per cow (or 0.02-0.1 IU/kg)	Every 30-60 minutes as needed; maximum 3 doses	Duration: Short-term; discontinue if no response Notes: For induction of labor, use low doses. For retained placenta, may be used after 24 hours postpartum. For milk let-down, 20-40 IU IV or IM.
Sheep/Goats	IV, IM	5-20 IU per ewe/doe (or 0.02-0.1 IU/kg)	Every 30-60 minutes as needed; maximum 3 doses	Duration: Short-term; discontinue if no response Notes: Use low doses; monitor for uterine rupture.
Rabbit	IM, IV	0.1-0.5 IU per rabbit (or 0.1-0.2 IU/kg)	Every 30 minutes as needed; maximum 2-3 doses	Duration: Short-term; discontinue if no response Notes: Use with caution; rabbits are prone to uterine adenocarcinoma, and oxytocin may cause rupture.
Birds	IM	Not established; use with caution. Some sources suggest 0.1-0.5 IU/kg for oviposition disorders, but efficacy is unproven.	Single dose; may repeat once after 30 minutes	Duration: Short-term Notes: Not routinely recommended; consider other treatments for egg binding.

Clinical Indications & Species Uses

General Indications

Induction of labor
Treatment of uterine inertia
Postpartum hemorrhage
Retained placenta
Milk let-down
Uterine evacuation

Dog (Canine)

Induction of labor (elective or therapeutic)
Treatment of uterine inertia (primary or secondary)
Management of postpartum hemorrhage
Facilitation of cesarean section (as adjunct)
Promotion of uterine involution and expulsion of placental remnants
Treatment of retained placenta (in combination with other therapy)
Milk let-down in bitches with agalactia

Cat (Feline)

Induction of labor
Treatment of uterine inertia
Management of postpartum hemorrhage
Facilitation of cesarean section
Milk let-down in queens with agalactia

Horse (Equine)

Induction of labor (controlled)
Treatment of uterine inertia
Management of postpartum hemorrhage
Evacuation of uterine contents (e.g., retained placenta, fetal mummification)
Assist in uterine involution
Milk let-down in mares

Cattle (Bovine)

Induction of labor (controlled calving)
Treatment of uterine inertia
Management of retained placenta (as adjunct)
Evacuation of uterine contents (e.g., fetal emphysema, mummification)
Milk let-down in cows with agalactia
Treatment of postpartum hemorrhage

Small Ruminants (Sheep / Goat)

Induction of labor (sheep, goats)
Treatment of uterine inertia
Management of retained placenta
Milk let-down in ewes and does

Rabbit & Small Mammals

Induction of labor (rarely used)
Treatment of uterine inertia (rarely used)
Milk let-down (rarely used)

Pharmacology & Mechanism of Action

Drug Class: Hormone | Pharmacological Group: Uterotonic / Oxytocic

Mechanism of Action: Oxytocin is a synthetic polypeptide hormone identical to the naturally occurring posterior pituitary hormone. It binds to specific G-protein-coupled oxytocin receptors on the myometrium (uterine smooth muscle) and myoepithelial cells of the mammary gland. Activation of these receptors increases intracellular calcium via the phospholipase C/inositol trisphosphate pathway, leading to enhanced uterine contractions. The sensitivity of the uterus to oxytocin is markedly increased by estrogen and decreased by progesterone. In the mammary gland, oxytocin stimulates contraction of myoepithelial cells, causing milk ejection (let-down). It also has vasopressin-like antidiuretic and vasoconstrictive effects at high doses.

Pharmacodynamics: Oxytocin produces rhythmic contractions of the uterine smooth muscle, which are more pronounced in the gravid uterus near term. The intensity and frequency of contractions increase with dose. It also promotes cervical dilation and uterine involution. In the mammary gland, it facilitates milk ejection by contracting myoepithelial cells. At high doses, it can cause vasoconstriction, antidiuresis, and transient hypotension followed by hypertension. The onset of action is rapid after IV administration (within 1 minute) and slightly slower after IM (within 3-5 minutes). The duration of action is short (20-30 minutes) due to rapid metabolism.

⚡ Pharmacokinetics Summary

Absorption: After oral administration, oxytocin is rapidly destroyed by gastrointestinal enzymes and is not absorbed systemically. It is well absorbed after intramuscular or subcutaneous injection. Intravenous administration provides immediate effect. Intranasal and buccal routes are used in humans but not commonly in veterinary medicine.

Distribution: Oxytocin is distributed throughout the extracellular fluid. It crosses the placenta to a limited extent. It is not significantly bound to plasma proteins. It is distributed to the mammary gland and uterus, where it exerts its effects.

Metabolism: Oxytocin is rapidly metabolized primarily in the liver and kidneys by peptidases (oxytocinase). It is also metabolized in the mammary gland and placenta. The half-life is short, approximately 3-5 minutes in plasma.

Excretion: Oxytocin is excreted mainly in the urine as inactive metabolites. A small amount is excreted unchanged in the bile. In lactating animals, small amounts may be excreted in milk.

Half-Life: Plasma half-life: 3-5 minutes in most species; biological half-life: 20-30 minutes.

Bioavailability: Oral: negligible; IM/SC: rapid and complete; IV: 100% (immediate).

Protein Binding: Negligible (<1%)

Available Formulations & Strengths

Injectable Solution 10 IU/mL, 20 IU/mL, 40 IU/mL (IV, IM, SC)

Nasal Spray (human) 40 IU/mL (Intranasal (not commonly used in veterinary medicine))

Contraindications & Clinical Warnings

Contraindications:

Hypersensitivity to oxytocin or any component
Cephalopelvic disproportion or fetal obstruction
Uterine rupture or risk of uterine rupture
Fetal distress or abnormal fetal presentation
Severe dystocia due to mechanical obstruction
Uterine torsion
Placenta previa (in humans; not applicable in animals)
When vaginal delivery is contraindicated (e.g., previous cesarean section with uterine scar, in some cases)

Warnings & Clinical Precautions:

Use with extreme caution in animals with cardiovascular disease, as oxytocin can cause hypotension and tachycardia.
Monitor uterine contractions and fetal heart rate closely during administration.
Avoid rapid IV injection; dilute and administer slowly to minimize hypotension.
Do not use for elective induction of labor unless facilities for emergency cesarean section are available.
Use in animals with multiple gestations may increase risk of uterine rupture.
In cattle, use caution in cows with history of dystocia or uterine torsion.
Oxytocin may cause water intoxication and hyponatremia if large volumes of electrolyte-free fluids are administered concurrently.
In horses, use with caution in mares with compromised cardiovascular status.
Not for use in animals with known hypersensitivity to the drug.
In food animals, observe withdrawal times.

Adverse Effects & Reactions

Common:

Uterine hyperstimulation (tetanic contractions)
Transient hypotension
Tachycardia
Nausea and vomiting (in some species)
Local irritation at injection site

Serious / Severe:

Uterine rupture
Fetal distress or death
Maternal death
Water intoxication and hyponatremia (with high doses and concurrent fluid therapy)
Cardiac arrhythmias
Hypertension (with high doses)
Anaphylactic reactions (rare)

Rare:

Allergic reactions
Seizures
Coma
Disseminated intravascular coagulation (DIC)
Myocardial ischemia

Key Drug Interactions

Interacting Drug / Class	Clinical Effect & Mechanism	Severity
Prostaglandins (e.g., dinoprost, cloprostenol)	Additive uterotonic effects; may cause uterine hyperstimulation and rupture. Use with caution and reduce doses.	High
Ergot alkaloids (e.g., ergonovine, methylergonovine)	Additive vasoconstrictive and uterotonic effects; risk of hypertension and uterine tetany.	High
Magnesium sulfate	May antagonize the uterine effects of oxytocin; monitor for reduced efficacy.	Moderate
Sympathomimetics (e.g., epinephrine, norepinephrine)	May reduce uterine blood flow and increase blood pressure; use with caution.	Moderate
Cyclopropane or halogenated anesthetics (e.g., halothane, isoflurane)	May increase risk of hypotension and cardiac arrhythmias; use with caution during anesthesia.	Moderate
Nonsteroidal anti-inflammatory drugs (NSAIDs)	May reduce the uterotonic effect of oxytocin by inhibiting prostaglandin synthesis; monitor efficacy.	Mild

Overdose & Toxicity Management

Signs of Toxicity:

Uterine hyperstimulation (tetanic contractions)
Uterine rupture
Fetal distress or death
Hypotension
Tachycardia
Cardiac arrhythmias
Water intoxication (hyponatremia, seizures, coma)
Respiratory distress

Emergency Treatment Protocol: Discontinue oxytocin immediately. Provide supportive care: administer IV fluids (balanced electrolyte solutions) to correct hypotension and electrolyte imbalances. For severe uterine hyperstimulation, administer a tocolytic agent such as terbutaline (0.01 mg/kg IV in dogs) or clenbuterol (in horses and cattle) to relax the uterus. Monitor cardiovascular status and treat arrhythmias as needed. In cases of water intoxication, restrict fluids and administer hypertonic saline if severe hyponatremia. Provide oxygen and respiratory support if necessary. In severe cases, surgical intervention (cesarean section) may be required if uterine rupture or fetal distress occurs.

Food Animal Withdrawal Times

🥩 Meat: 0 days🥛 Milk: 0 days🥚 Eggs: 0 days

Oxytocin is a naturally occurring hormone and is rapidly metabolized; no withdrawal periods are required for meat, milk, or eggs. However, always follow local regulations and label instructions.

Storage, Handling & Regulatory Information

Storage Temperature: Store at 2-8°C (refrigerate). Do not freeze.

Light Sensitivity: Light-sensitive — protect from direct exposure.

Handling & Special Conditions: Protect from light. Keep in original carton until use. Do not use if solution is discolored or contains particulate matter.

Dispensing Status: Prescription Required (Rx Only)

Approval Status: FDA-approved for use in cattle, horses, dogs, and cats. Other species may be extra-label.

Extra-Label (Off-Label) Use: In the US, oxytocin is a prescription drug. Extra-label use in food animals is permitted under AMDUCA with veterinary oversight, but must follow withdrawal times and residue avoidance. In some countries, oxytocin may be restricted for use in food animals due to concerns about milk let-down and potential for abuse.

Clinical Pearls & Practice Notes

💡 Clinical Insights: Oxytocin is a critical drug for managing uterine inertia and postpartum hemorrhage in veterinary practice. It is essential to confirm that there is no physical obstruction before administering oxytocin, as it can cause uterine rupture. Use the lowest effective dose and monitor the animal closely. In cattle, oxytocin is commonly used for milk let-down and retained placenta, but its use for induction of labor should be carefully considered due to risks. In small animals, oxytocin is often used in conjunction with calcium and glucose for uterine inertia. Always have emergency surgical facilities available when using oxytocin for induction of labor. In food animals, observe withdrawal times and follow local regulations. Oxytocin should be stored refrigerated and protected from light to maintain potency.

References & Literature

📚 Plumb's Veterinary Drug Handbook
📚 Papich Veterinary Pharmacology and Therapeutics
📚 Compendium of Veterinary Products (CVP)